Atlas Trials

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer

Clinical trial NCT01654367 · UNKNOWN

Trial details

NCT number
NCT01654367
Sponsor
Tianjin Medical University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2012-01-01
Primary completion
2012-12-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.